Literature DB >> 33215784

Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions.

Xiaosheng Fang1,2, Zhongling Sun3, Zijun Y Xu-Monette1,4, Ken H Young1,4.   

Abstract

Entities:  

Year:  2020        PMID： 33215784      PMCID： PMC7794201          DOI： 10.1002/onco.13605

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  19 in total

1.  Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot.

Authors:  B CASTLEMAN; V W TOWNE
Journal:  N Engl J Med       Date:  1954-09-02       Impact factor: 91.245

2.  Use of a claims database to characterize and estimate the incidence rate for Castleman disease.

Authors:  Nikhil Munshi; Maneesha Mehra; Helgi van de Velde; Avinash Desai; Ravi Potluri; Jessica Vermeulen
Journal:  Leuk Lymphoma       Date:  2014-09-29

3.  Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; Ruth-Anne Langan; Alberto Sada Japp; Helen L Partridge; Sheila K Pierson; Amrit Singh; Daniel J Arenas; Jason R Ruth; Christopher S Nabel; Katie Stone; Mariko Okumura; Anthony Schwarer; Fábio Freire Jose; Nelson Hamerschlak; Gerald B Wertheim; Michael B Jordan; Adam D Cohen; Vera Krymskaya; Arthur Rubenstein; Michael R Betts; Taku Kambayashi; Frits van Rhee; Thomas S Uldrick
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

Review 4.  Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum
Journal:  Blood       Date:  2018-11-29       Impact factor: 22.113

5.  Increased mTOR activation in idiopathic multicentric Castleman disease.

Authors:  Daniel J Arenas; Katherine Floess; Dale Kobrin; Ruth-Anne Langan Pai; Maya B Srkalovic; Mark-Avery Tamakloe; Rozena Rasheed; Jasira Ziglar; Johnson Khor; Sophia A T Parente; Sheila K Pierson; Daniel Martinez; Gerald B Wertheim; Taku Kambayashi; Joseph Baur; David T Teachey; David C Fajgenbaum
Journal:  Blood       Date:  2020-05-07       Impact factor: 22.113

Review 6.  HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy.

Authors:  David C Fajgenbaum; Frits van Rhee; Christopher S Nabel
Journal:  Blood       Date:  2014-03-12       Impact factor: 22.113

7.  Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease.

Authors:  Ruth-Anne Langan Pai; Alberto Sada Japp; Michael Gonzalez; Rozena F Rasheed; Mariko Okumura; Daniel Arenas; Sheila K Pierson; Victoria Powers; Awo Akosua Kesewa Layman; Charlly Kao; Hakon Hakonarson; Frits van Rhee; Michael R Betts; Taku Kambayashi; David C Fajgenbaum
Journal:  JCI Insight       Date:  2020-05-07

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

Review 9.  Idiopathic multicentric Castleman's disease: a systematic literature review.

Authors:  Amy Y Liu; Christopher S Nabel; Brian S Finkelman; Jason R Ruth; Razelle Kurzrock; Frits van Rhee; Vera P Krymskaya; Dermot Kelleher; Arthur H Rubenstein; David C Fajgenbaum
Journal:  Lancet Haematol       Date:  2016-03-17       Impact factor: 18.959

10.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.